Antibacterial activities and structure–activity relationships of a panel of 48 compounds from Kenyan plants against multidrug resistant phenotypes
Leonidah Kerubo Omosa(University of Nairobi), Victor Kuete(Université de Dschang), Armelle T. Mbaveng(Université de Dschang), Igor K. Voukeng(Université Libre de Bruxelles), Ruth A. Omolle(University of Nairobi), Thomas Efferth(Johannes Gutenberg University Mainz), Solomon Derese(University of Nairobi), Jacob O. Midiwo(University of Nairobi), Simplice B. Tankeo(Université de Dschang), Armel Jackson Seukep(University of Buea), Joachim K. Dzotam(Université de Dschang), John Isemeki(University of Nairobi)
Cited by 96
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
The role of p53 in cancer drug resistance and targeted chemotherapy
|Oncotarget|2016|580
Best practice in research – Overcoming common challenges in phytopharmacological research
|Journal of Ethnopharmacology|2019|548
Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress‐ and aging‐related diseases
|Medicinal Research Reviews|2020|328
Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets
|Frontiers in Pharmacology|2017|142